<Record>
<Term>Myeloablative Agonists</Term>
<SemanticType>Pharmacologic Substance</SemanticType>
<ParentTerm>Antineoplastic Agents</ParentTerm>
<ParentTerm>Immunosuppressive Agents</ParentTerm>
<ClassificationPath>Chemical Actions and Uses/Pharmacologic Actions/Physiological Effects of Drugs/Immunologic Factors/Immunosuppressive Agents/Myeloablative Agonists</ClassificationPath>
<ClassificationPath>Chemical Actions and Uses/Pharmacologic Actions/Therapeutic Uses/Antineoplastic Agents/Myeloablative Agonists</ClassificationPath>
<BroaderTerm>Therapeutic Uses</BroaderTerm>
<BroaderTerm>Pharmacologic Actions</BroaderTerm>
<BroaderTerm>Antineoplastic Agents</BroaderTerm>
<BroaderTerm>Myeloablative Agonists</BroaderTerm>
<BroaderTerm>Chemical Actions and Uses</BroaderTerm>
<BroaderTerm>Immunosuppressive Agents</BroaderTerm>
<BroaderTerm>Immunologic Factors</BroaderTerm>
<BroaderTerm>Physiological Effects of Drugs</BroaderTerm>
<Synonym>Myeloablative Agonist</Synonym>
<Synonym>Myeloablative Agonists</Synonym>
<Description>Agents that destroy bone marrow activity. They are used to prepare patients for BONE MARROW TRANSPLANTATION or STEM CELL TRANSPLANTATION.</Description>
<Source>MeSH</Source>
</Record>
